Published in J Invest Dermatol on October 01, 1984
The lupus band test in systemic lupus erythematosus patients. Ther Clin Risk Manag (2011) 0.82
Immunofluorescence microscopy of healthy skin from patients with systemic lupus erythematosus: more than just the lupus band. Ann Rheum Dis (1992) 0.75
Correlation of cutaneous immunoreactants in lesional skin with the serological disorders and disease activity of systemic lupus erythematosus. PLoS One (2013) 0.75
Lichen sclerosus. J Am Acad Dermatol (1995) 2.84
Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol (1979) 2.53
Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet (1996) 2.46
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol (1981) 1.76
Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol (1995) 1.72
Bacteriophage-bacteriophage interactions in the evolution of pathogenic bacteria. Trends Microbiol (2001) 1.49
p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene (2007) 1.38
Transient receptor potential vanilloid 1-immunopositive neurons in the mouse are more prevalent within colon afferents compared to skin and muscle afferents. Neuroscience (2006) 1.36
Cimetidine-associated exacerbation of cutaneous lupus erythematosus. Arch Intern Med (1982) 1.34
Antigenuria in St. Louis encephalitis. Am J Trop Med Hyg (1980) 1.34
Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci (1994) 1.29
Differential dependency of unmyelinated and A delta epidermal and upper dermal innervation on neurotrophins, trk receptors, and p75LNGFR. Dev Biol (1998) 1.29
THE VEGETATION OF THE HOT SPRINGS OF YELLOWSTONE PARK. Science (1897) 1.28
Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest (1977) 1.26
Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol (1983) 1.26
DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis. Clin Immunol Immunopathol (1978) 1.25
Furniture-induced erythema ab igne. J Am Acad Dermatol (1996) 1.21
Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry (1986) 1.20
The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice. J Invest Dermatol (1975) 1.19
A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. J Thorac Cardiovasc Surg (2001) 1.19
Epidermal changes in vitamin B 12 deficiency. Arch Dermatol (1973) 1.18
Neurotrophins, nociceptors, and pain. Microsc Res Tech (1999) 1.18
Overexpression of nerve growth factor in skin selectively affects the survival and functional properties of nociceptors. J Neurosci (1999) 1.18
Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1. J Immunol (1983) 1.17
Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res (1991) 1.15
Epithelial overexpression of BDNF or NT4 disrupts targeting of taste neurons that innervate the anterior tongue. Dev Biol (2001) 1.13
Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease. J Clin Invest (1974) 1.11
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential. Cancer (1993) 1.10
An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay. Ann Intern Med (1978) 1.08
Mixed connective tissue disease syndrome. Arch Dermatol (1977) 1.08
Cutaneous overexpression of NT-3 increases sensory and sympathetic neuron number and enhances touch dome and hair follicle innervation. J Cell Biol (1996) 1.05
Tolerance or hypersensitivity to 2,4-dinitro-1-fluorobenzene: the role of Langerhans cell density within epidermis. J Invest Dermatol (1980) 1.04
Overexpression of brain-derived neurotrophic factor enhances sensory innervation and selectively increases neuron number. J Neurosci (1999) 1.03
Basic and clinical aspects of visceral sensation: transmission in the CNS. Neurogastroenterol Motil (2005) 1.03
Chronic cutaneous lupus erythematosus (DLE)--a clinical and laboratory investigation of 80 patients. Medicine (Baltimore) (1976) 1.02
An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate. J Lab Clin Med (1978) 1.02
Molecular characteristics of SS-B/La and SS-A/Ro cellular antigens. J Invest Dermatol (1985) 1.02
Subepidermal deposition of immunoglobulin in NZB/NZW F hybrid mice. J Immunol (1975) 1.02
Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus. Arch Dermatol (1975) 1.00
Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry (1985) 1.00
Cutaneous necrotizing vasculitis and related disorders. Ann Allergy (1976) 0.99
Plasma homovanillic acid concentration and the severity of schizophrenic illness. Science (1985) 0.98
Deletion of P2X3 receptors blunts gastro-oesophageal sensation in mice. Neurogastroenterol Motil (2009) 0.98
Murine graft-versus-host skin disease: a chronologic and quantitative analysis of two histologic patterns. J Invest Dermatol (1983) 0.96
Beneficial effect of an essential fatty acid deficient diet in NZB/NZW F1 mice. J Invest Dermatol (1981) 0.96
Sodium channel expression in NGF-overexpressing transgenic mice. J Neurosci Res (1999) 0.95
High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest (1981) 0.93
Origin of spinal cord axons in the lizard regenerated tail: supernormal projections from local spinal neurons. J Comp Neurol (1990) 0.93
Effect of the War on the Distribution of Full-time Local Health Officers. Am J Public Health Nations Health (1945) 0.92
Overexpression of GDNF induces and maintains hyperinnervation of muscle fibers and multiple end-plate formation. Exp Neurol (2001) 0.92
The distribution of enkephalinlike immunoreactivity in the telencephalon of the adult and developing domestic chicken. J Comp Neurol (1984) 0.90
Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions. J Am Acad Dermatol (1983) 0.90
Idiopathic atrophie blanche. J Am Acad Dermatol (1983) 0.87
Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus. Lupus (1997) 0.87
Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia. Diabetologia (1978) 0.86
Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol (1984) 0.84
Epidermal nucleolar IgG deposition in clinically normal skin: clinical and serologic features of eight patients. Arch Dermatol (1978) 0.84
CKholinergic mechanisms and anterior pituitary hormone secretion. Biol Psychiatry (1980) 0.84
Maturation of cutaneous sensory neurons from normal and NGF-overexpressing mice. J Neurophysiol (2000) 0.84
Unusual numbers and distribution of Langerhans cells in skin with unique immunologic properties. J Invest Dermatol (1980) 0.84
DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. Hum Gene Ther (1999) 0.84
Perturbation of epidermal Langerhans cells in immunosuppressed human renal allograft recipients. Transplantation (1984) 0.84
The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus. Hepatology (1985) 0.84
Conversion of discoid lupus erythematosus to mixed connective tissue disease. J Rheumatol (1977) 0.83
Lithium's effect of parathyroid hormone. Am J Psychiatry (1981) 0.83
NGF modulates sympathetic innervation of lymphoid tissues. J Neurosci (1995) 0.83
Potentiation of transmission at Ia-motoneuron connections induced by repeated short bursts of afferent activity. J Neurophysiol (1985) 0.83
Expression of Ro/SS-A antigen in human skin and heart. J Invest Dermatol (1985) 0.83
Correlation of disease activity and Clq-binding immune complexes with the neutrophil inclusions which form in the presence of SLE sera. Clin Exp Immunol (1980) 0.82
Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice. Exp Hematol (1997) 0.82
Levels of nerve growth factor and neurotrophin-3 are affected differentially by the presence of p75 in sympathetic neurons in vivo. J Comp Neurol (2000) 0.82
Overexpression of nerve growth factor in skin increases sensory neuron size and modulates Trk receptor expression. Eur J Neurosci (1997) 0.82
Skin-derived nerve growth factor blocks programmed cell death in the trigeminal ganglia but does not enhance neuron proliferation. Mech Dev (2001) 0.81
Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors. Clin Cancer Res (1996) 0.81
Diabetes is associated with autoimmunity in the New Zealand obese (NZO) mouse. Diabetes (1980) 0.81
A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol (1979) 0.81
Cellular localization of Pan-trk immunoreactivity and trkC mRNA in the enteric nervous system. J Comp Neurol (1996) 0.80
Overexpression of nerve growth factor in epidermis disrupts the distribution and properties of sympathetic innervation in footpads. J Comp Neurol (1998) 0.80
Level of p75 receptor expression in sensory ganglia is modulated by NGF level in the target tissue. J Neurobiol (1998) 0.80
Effects of cholinergic stimulation on pituitary hormone release. Psychoneuroendocrinology (1982) 0.80
Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide. Clin Cancer Res (1999) 0.80
Excess target-derived neurotrophin-3 alters the segmental innervation of the skin. Eur J Neurosci (2001) 0.80
Excess nerve growth factor in the periphery does not obscure development of whisker-related patterns in the rodent brain. J Comp Neurol (1996) 0.80
Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies. J Am Geriatr Soc (1985) 0.79
Fibrinolytic therapy for vasculitis of atrophie blanche. Arch Dermatol (1974) 0.79
The immunology of psoriasis. Pharmacol Ther (1981) 0.79
Immunoglobulins in the larynx in systemic lupus erythematosus. Arch Dermatol (1973) 0.79
Distribution of preproenkephalin mRNA in the chicken and pigeon telencephalon. J Comp Neurol (1994) 0.79
TRAF family member-associated NF-kappa B activator (TANK) expression increases in injured sensory neurons and is transcriptionally regulated by Sox11. Neuroscience (2012) 0.79
Amplitude modulation of EPSPs in motoneurons in response to a frequency-modulated train in single la afferent fibers. J Neurosci (1986) 0.79
The differential effects of cyclophosphamide and 6-mercaptopurine on the renal disease and skin immunoglobulin deposits of the NZB-NZW F1 hybrid mice. Agents Actions (1976) 0.79
Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies. J Am Geriatr Soc (1985) 0.79
Modulation of EPSP amplitude during high frequency stimulation depends on the correlation between potentiation, depression and facilitation. Brain Res (1988) 0.79
Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy. Cutis (1980) 0.79
Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients. Neuropsychopharmacology (1987) 0.79
Neuroendocrine and neurochemical measurements in depression. Am J Psychiatry (1981) 0.79
Skin manifestations of SLE. Clin Rheum Dis (1982) 0.79
RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects. Biol Psychiatry (1987) 0.78
Comparison of circulating T and B lymphocytes in discoid versus systemic lupus erythematosus. Clin Immunol Immunopathol (1976) 0.78